A literature review on function and regulation mechanism of DKK4

Xiaoli Lou1, Yuchen Meng1, Yanqiang Hou1

  • 1Department of Central Laboratory, Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Insights

Dickkopf-related protein 4 (DKK4) is a key regulator of Wnt/β-catenin signaling. This review details DKK4

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Dickkopf-related protein 4 (DKK4) is a member of the dickkopf family.
  • DKK4 functions as an inhibitor of the Wnt/β-catenin signaling pathway.
  • Aberrant DKK4 expression is implicated in various diseases.

Purpose of the Study:

  • To review genetic variations (SNPs, CNVs), epigenetic modifications (hypermethylation), and regulatory mechanisms of DKK4.
  • To examine the correlation between DKK4 and clinicopathological parameters, and its role in chemotherapeutic resistance.
  • To explore the involvement of DKK4 in diverse biological processes and diseases.

Main Methods:

  • Literature review of studies on DKK4.
  • Analysis of DKK4's role in Wnt/β-catenin and Wnt-JNK pathways.
  • Compilation of data on DKK4 expression patterns in different cancers.

Main Results:

  • DKK4 expression is upregulated in Renal Cell Carcinoma (RCC), Colorectal Cancer, Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), and Epithelial Ovarian Cancer (EOC).
  • DKK4 expression is downregulated in Hepatocellular Carcinoma (HCC).
  • DKK4 influences tumor growth, invasion, migration, and chemotherapy resistance, as well as osteoblastogenesis, hair, and meibomian gland formation. DKK4 is also linked to schizophrenia.

Conclusions:

  • DKK4 is a significant factor in cancer development and progression across multiple tumor types.
  • DKK4's multifaceted roles extend beyond cancer to developmental processes and neurological disorders.
  • Further research into DKK4's mechanisms could yield novel therapeutic strategies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
347
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.6K